Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.

Source:http://linkedlifedata.com/resource/pubmed/id/11297268

Download in:

View as

General Info

PMID
11297268